Analysts think ENTA stock price could increase by 129%
Sep 05, 2025, 11:25 AM
16.12%
What does ENTA do
Enanta Pharmaceuticals, based in Watertown, Massachusetts, focuses on developing small molecule drugs for viral infections and liver diseases, including treatments for RSV and hepatitis C. The company went public in March 2013 and employs 145 people.
8 analysts think ENTA stock price will increase by 129.21%. The current median analyst target is $20.40 compared to a current stock price of $8.90. The lowest analysts target is $7.07 and the highest analyst target is $26.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.